• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TSPO PET 成像作为一种强大的非侵入性生物标志物,用于患者来源的原位大鼠模型中的弥漫性内在脑桥胶质瘤。

TSPO PET Imaging as a Potent Non-Invasive Biomarker for Diffuse Intrinsic Pontine Glioma in a Patient-Derived Orthotopic Rat Model.

机构信息

BioMaps, Service Hospitalier Frédéric Joliot, CEA, CNRS, Inserm, University of Paris-Saclay, 4 Place du Général Leclerc, 91401 Orsay, France.

Institut de Recerca, Sant Joan de Déu Hospital, Carrer de Sant Quinti, 77, 08041 Barcelona, Spain.

出版信息

Int J Mol Sci. 2022 Oct 18;23(20):12476. doi: 10.3390/ijms232012476.

DOI:10.3390/ijms232012476
PMID:36293329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9603997/
Abstract

Diffuse intrinsic pontine gliomas (DIPG), the first cause of cerebral pediatric cancer death, will greatly benefit from specific and non-invasive biomarkers for patient follow-up and monitoring of drug efficacy. Since biopsies are challenging for brain tumors, molecular imaging may be a technique of choice to target and follow tumor evolution. So far, MR remains the imaging technique of reference for DIPG, although it often fails to define the extent of tumors, an essential parameter for therapeutic efficacy assessment. Thanks to its high sensitivity, positron emission tomography (PET) offers a unique way to target specific biomarkers in vivo. We demonstrated in a patient-derived orthotopic xenograft (PDOX) model in the rat that the translocator protein of 18 kDa (TSPO) may be a promising biomarker for monitoring DIPG tumors. We studied the distribution of 18F-DPA-714, a TSPO radioligand, in rats inoculated with HSJD-DIPG-007 cells. The primary DIPG human cell line HSJD-DIPG-007 highly represents this pediatric tumor, displaying the most prevalent DIPG mutations, H3F3A (K27M) and ACVR1 (R206H). Kinetic modeling and parametric imaging using the brain 18F-DPA-714 PET data enabled specific delineation of the DIPG tumor area, which is crucial for radiotherapy dose management.

摘要

弥漫性内在脑桥神经胶质瘤(DIPG)是小儿脑癌死亡的首要原因,如果能找到针对该疾病的特异性、非侵入性生物标志物,用于患者随访和药物疗效监测,将大为受益。由于对脑肿瘤进行活检具有挑战性,因此分子成像可能是一种靶向和跟踪肿瘤演变的首选技术。到目前为止,磁共振成像(MR)仍然是 DIPG 的参考成像技术,尽管它往往无法确定肿瘤的范围,而这是评估治疗效果的一个重要参数。正电子发射断层扫描(PET)凭借其高灵敏度,为靶向特定生物标志物提供了一种独特的体内方法。我们在大鼠的 DIPG 患者来源的原位异种移植(PDOX)模型中证明,18kDa 转位蛋白(TSPO)可能是监测 DIPG 肿瘤的一种很有前途的生物标志物。我们研究了 18F-DPA-714(一种 TSPO 放射性配体)在 HSJD-DIPG-007 细胞接种大鼠中的分布情况。原发性 DIPG 人细胞系 HSJD-DIPG-007 高度代表了这种小儿肿瘤,显示出最常见的 DIPG 突变,H3F3A(K27M)和 ACVR1(R206H)。使用大脑 18F-DPA-714 PET 数据进行的动力学建模和参数成像,能够特异性地划定 DIPG 肿瘤区域,这对放疗剂量管理至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e709/9603997/c47d6c53de93/ijms-23-12476-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e709/9603997/48f41adc93dc/ijms-23-12476-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e709/9603997/a95c44aa1a19/ijms-23-12476-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e709/9603997/e81996f817c7/ijms-23-12476-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e709/9603997/c47d6c53de93/ijms-23-12476-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e709/9603997/48f41adc93dc/ijms-23-12476-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e709/9603997/a95c44aa1a19/ijms-23-12476-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e709/9603997/e81996f817c7/ijms-23-12476-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e709/9603997/c47d6c53de93/ijms-23-12476-g004.jpg

相似文献

1
TSPO PET Imaging as a Potent Non-Invasive Biomarker for Diffuse Intrinsic Pontine Glioma in a Patient-Derived Orthotopic Rat Model.TSPO PET 成像作为一种强大的非侵入性生物标志物,用于患者来源的原位大鼠模型中的弥漫性内在脑桥胶质瘤。
Int J Mol Sci. 2022 Oct 18;23(20):12476. doi: 10.3390/ijms232012476.
2
Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models.贝伐单抗靶向弥漫性脑桥内生型胶质瘤:89Zr-贝伐单抗PET成像在脑肿瘤模型中的结果
Mol Cancer Ther. 2016 Sep;15(9):2166-74. doi: 10.1158/1535-7163.MCT-15-0558. Epub 2016 Jun 20.
3
Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG).回顾性分析弥漫性内在脑桥胶质瘤(DIPG)的 MRI 特征与组织学和分子标志物的一致性。
Childs Nerv Syst. 2020 Apr;36(4):697-704. doi: 10.1007/s00381-019-04463-y. Epub 2019 Dec 17.
4
Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.基于生物标志物的小鼠模型中弥漫性脑桥内在胶质瘤的PET成像
Cancer Res. 2017 Apr 15;77(8):2112-2123. doi: 10.1158/0008-5472.CAN-16-2850. Epub 2017 Jan 20.
5
Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.使用 N,N-二乙基-2-(2-(4-(2-18F-氟乙氧基)苯基)-5,7-二甲基吡唑并[1,5-a]嘧啶-3-基)乙酰胺对胶质瘤中 TSPO 表达的定量临床前成像。
J Nucl Med. 2012 Feb;53(2):287-94. doi: 10.2967/jnumed.111.095653. Epub 2012 Jan 17.
6
Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.脂质体阿霉素对流增强递送治疗小儿弥漫性脑桥内在型胶质瘤和丘脑高级别胶质瘤的临床前评估
J Neurosurg Pediatr. 2017 May;19(5):518-530. doi: 10.3171/2016.9.PEDS16152. Epub 2017 Feb 17.
7
Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TβRI cross-talk in diffuse intrinsic pontine glioma.ACVR1 G328V 和 R206H 突变的差异激酶活性及其对弥漫性内生脑桥胶质瘤中 TβRI 交叉对话的影响。
Sci Rep. 2020 Apr 9;10(1):6140. doi: 10.1038/s41598-020-63061-0.
8
Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma.逆转癌症基因表达可鉴定弥漫性内生脑桥胶质瘤的再利用药物。
Acta Neuropathol Commun. 2022 Oct 23;10(1):150. doi: 10.1186/s40478-022-01463-z.
9
ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis.ACVR1 R206H 与 H3.1K27M 协同促进弥漫性内在脑桥神经胶质瘤的发病机制。
Nat Commun. 2019 Mar 4;10(1):1023. doi: 10.1038/s41467-019-08823-9.
10
Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study.临床前TSPO配体PET用于可视化人胶质瘤异种移植瘤:一项初步研究。
PLoS One. 2015 Oct 30;10(10):e0141659. doi: 10.1371/journal.pone.0141659. eCollection 2015.

引用本文的文献

1
From Seeing to Healing: The Clinical Potential of Radiotracers in Pediatric Neuro-Oncology.从观察到治愈:放射性示踪剂在儿童神经肿瘤学中的临床潜力
Cancers (Basel). 2025 Jun 7;17(12):1905. doi: 10.3390/cancers17121905.
2
Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas.小儿型弥漫性高级别胶质瘤三种最常见亚类的异种移植瘤建立及肿瘤负荷评估方法
J Neurooncol. 2025 May;172(3):599-611. doi: 10.1007/s11060-025-04954-w. Epub 2025 Feb 17.

本文引用的文献

1
Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization.用 TSPO 成像神经炎症:细胞来源和亚细胞定位的新视角。
Pharmacol Ther. 2022 Jun;234:108048. doi: 10.1016/j.pharmthera.2021.108048. Epub 2021 Nov 27.
2
Mitochondrial Translocator Protein (TSPO) Expression in the Brain After Whole Body Gamma Irradiation.全身γ射线照射后大脑中线粒体转位蛋白(TSPO)的表达
Front Cell Dev Biol. 2021 Oct 25;9:715444. doi: 10.3389/fcell.2021.715444. eCollection 2021.
3
The Role of PET in Supratentorial and Infratentorial Pediatric Brain Tumors.
正电子发射断层扫描在幕上和幕下小儿脑肿瘤中的作用。
Curr Oncol. 2021 Jul 5;28(4):2481-2495. doi: 10.3390/curroncol28040226.
4
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
5
Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments.针对脑癌中的神经炎症:揭示机制、药理学靶点及神经药物研发
Front Pharmacol. 2021 May 18;12:680021. doi: 10.3389/fphar.2021.680021. eCollection 2021.
6
PET Molecular Imaging: A Holistic Review of Current Practice and Emerging Perspectives for Diagnosis, Therapeutic Evaluation and Prognosis in Clinical Oncology.正电子发射断层扫描(PET)分子影像学:对当前临床肿瘤学中诊断、治疗评估和预后的实践现状和新兴观点的全面综述。
Int J Mol Sci. 2021 Apr 16;22(8):4159. doi: 10.3390/ijms22084159.
7
Imaging of the glioma microenvironment by TSPO PET.TSPO PET 对脑胶质瘤微环境的成像。
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):174-185. doi: 10.1007/s00259-021-05276-5. Epub 2021 Mar 15.
8
Diffuse intrinsic pontine glioma: current insights and future directions.弥漫性脑桥内生型胶质瘤:当前见解与未来方向
Chin Neurosurg J. 2021 Jan 11;7(1):6. doi: 10.1186/s41016-020-00218-w.
9
Correlation of multimodal F-DOPA PET and conventional MRI with treatment response and survival in children with diffuse intrinsic pontine gliomas.多模态 F-DOPA PET 与常规 MRI 与弥漫性内在脑桥胶质瘤患儿治疗反应和生存的相关性。
Theranostics. 2020 Oct 25;10(26):11881-11891. doi: 10.7150/thno.50598. eCollection 2020.
10
The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma.转运蛋白TSPO在胶质母细胞瘤特征中的作用
Cancers (Basel). 2020 Oct 14;12(10):2973. doi: 10.3390/cancers12102973.